3
2
1

【The YinFeng Life Continuation Project Debuts at the 2026 Annual Meeting of the Chinese Medical Association's Medical Ethics Branch—Ethics Leading Biotech Toward Benevolent Innovation】

2026/07/22

The debut and discourse of the YinFeng Life Continuation Project not only served as an authoritative demonstration of its own ethical governance framework but also contributed practical wisdom toward establishing industry norms.

Yinfeng Foundation Honored as "2025 Public Welfare Donor" by Jinan Red Cross

2026/04/24

Looking ahead, Yinfeng Foundation will use this recognition as an opportunity to further deepen its strategic collaboration with the Jinan Red Cross, expand cooperation in areas such as life health and emergency response, and continue to empower efforts to accelerate the construction of a "new, strong, excellent, rich, beautiful, and high-quality" modern socialist strong capital city, contributing even more Yinfeng strength to this endeavor.

Yinfeng Life Science Research Institute, in Collaboration with University of Science and Technology of China, Develops CryoSIM Platform, Published in Top Analytical Chemistry Journal Revolutionizing Oocyte Membrane Permeability Analysis Technology

2026/03/04

The team successfully developed the CryoSIM platform, an intelligent microfluidics and deep learning-integrated system. This platform deeply integrates core technologies of deep learning and microfluidics to enable high-throughput, high-precision automated analysis of oocyte membrane permeability. It provides a novel technological tool for optimizing and advancing the clinical translation of oocyte cryopreservation techniques. Additionally, it offers an innovative practical paradigm for the application of artificial intelligence in low-temperature biomedicine and reproductive medicine.

Public Welfare Partnership: A Special Letter from the Jinan Red Cross

2026/02/02

On the afternoon of January 30, 2026, the Jinan Red Cross presented a letter of special significance to the Shandong Yinfeng Life Science Public Welfare Foundation (hereinafter referred to as the Yinfeng Foundation).

World’s First Achievement Highlights Brand Leadership

2026/01/19

In the future, Yinfeng Life Science Research Institute will continue to uphold its mission of "Dedicated to Medical Technology, Safeguarding Human Health." It will empower brand building with more original and pioneering scientific and technological achievements, contributing wisdom and strength to Shandong's goal of building a national regional innovation hub and promoting Chinese brands on the global stage.

Global First Ovarian Tissue Dual Activation Technology Debuts at 2025 Jinan Achievements Conference

2026/01/04

Currently, the ovarian tissue dual activation technology has been successfully applied in clinical practice at Beijing University of Chinese Medicine Shenzhen (Longgang) Hospital, having treated over 400 patients with a treatment success rate of 70%. Over the next three years, Shandong Yinfeng Life Science Research Institute plans to use Jinan as a center to gradually expand the transformation and application of this technological achievement nationwide.

2022-08-01

Yinfeng Low Temperature Medicine: -196 ℃, Exploring the Chinese Temperature of Life Sciences

In the extraordinary decade, Chinese companies have emerged with countless warm brand stories, which we call "Chinese Temperature". Starting from August 2022, the Advertising Research Center of Shandong University, the Shandong Provincial Brand Building Promotion Association, and the Qilu Evening News One Point Think Tank jointly plan the "China Temperature" public welfare communication action, aiming to showcase the "China Temperature" of Shandong enterprises from multiple perspectives, accumulate brand strength, forge ahead on a new journey, and contribute to the new era.

2022-07-26

Xiao International Education and Research Camp Enters Shandong Yinfeng Life Science Research Institute

Shandong Yinfeng Life Science Research Institute will continue to uphold the mission and responsibility of "dedicating medical technology and ensuring human health", and continue to play the role of "Life Science Education Popularization Base" to support the progress of life science and low-temperature medicine!

2022-03-29

Zhang Haidong and his delegation from Shandong First Medical University (Shandong Academy of Medical Sciences) visited and conducted research at Yinfeng Biotechnology Group

On March 29th, Zhang Haidong, Executive Vice President of the School of Clinical and Basic Medicine at Shandong First Medical University (Shandong Academy of Medical Sciences), Yue Yun, Deputy Secretary of the Party Committee, and Wang Dandan, Vice President, visited and conducted research at Yinfeng Biotechnology Group. Zhang Cheng, President of Yinfeng Biotechnology Group, Zhang Guirong, Assistant to the President and Director of Research and Development Department, and Hu Jinkun, Director of Human Resources Department, accompanied the delegation.

2022-03-11

The on-site technical exchange meeting between Shandong Yinfeng Life Science Research Institute and Shandong University Qilu Hospital Orthopedics Department was successfully held

On the afternoon of March 8th, Jia Chunsheng, Vice President of Shandong Yinfeng Life Science Research Institute (our foundation's research unit), Liu Zhicheng, General Manager of Yinfeng Health Technology Service Co., Ltd., and Zang Chuanbao, Director of Cryogenic Medicine Research Center, were invited to participate in a hospital enterprise cooperation intention exchange meeting organized by the Orthopedics Department of Qilu Hospital, Shandong University. Liu Xinyu, Executive Deputy Director of Orthopedics and Director of Spinal Surgery at Qilu Hospital of Shandong University, Zhu Lei, Deputy Director of Orthopedics and Director of Hand and Foot Surgery, Cheng Lei, Deputy Director of Spinal Surgery, Xu Qingjia, Deputy Director of Hand and Foot Surgery, and more than 30 professional doctors and technical experts from the orthopedics department participated in this meeting.

2022-03-08

The cryogenic medicine team of our hospital won the 25th invention patent

Recently, the Cryomedicine Center of Shandong Yinfeng Life Sciences Research Institute (the research unit of our foundation) once again obtained the invention patent for "a placental tissue matrix material and its preparation method". Up to now, the total number of patent authorizations granted by the cryogenic medicine team from the State Intellectual Property Office has reached 25.

2022-03-04

-196℃+3D printing, new technology makes biological tissue storage more convenient

According to a recent paper in the journal "Materials", researchers from Brigham and Women's Hospital and Harvard Medical School combined 3D bioprinting with cryopreservation technology to create tissue that can be stored in a freezer at minus 196°C. , and can be defrosted in minutes for immediate use.

< 1...373839...46 >
< 1234...28 >